Uno Masafumi, Tamaki Yukihisa, Burioka Hiroshi, Nagano Natsuko, Sonoyama Yoko
Radiation Oncology, Shimane University Faculty of Medicine, Izumo, JPN.
Cureus. 2024 Nov 4;16(11):e73007. doi: 10.7759/cureus.73007. eCollection 2024 Nov.
Malignant psoas syndrome is caused by a malignant tumor infiltrating the psoas muscle and is characterized by severe pain. Currently, no definitive diagnostic or therapeutic approaches have been established for this condition. Although multiple medications are often used for pain relief, pain management can often be challenging, and there are various treatment options. Here, we report a case of a Japanese man in his 60s who was diagnosed with malignant psoas syndrome due to metastasis of myxoid liposarcoma. Despite undergoing several pharmacological treatments for severe pain, their effects were insufficient. Palliative radiation therapy was therefore planned and started to relieve pain. We discussed radiation therapy methods. Since there was no previous literature on treatment with single doses exceeding 3 Gy and the attending physician expected the patient to have a little longer survival time, we decided to treat 39 Gy in 13 fractions of radiation therapy. Early pain relief was achieved with 24 Gy in eight fractions. Radiation therapy was continued without change after the pain improved. The treatment was terminated at 36 Gy in 12 fractions due to the deterioration of the patient's general condition caused by the progression of metastases throughout the body. The patient died two days after the end of his treatment (18 days after the start of radiation therapy) due to exacerbation of his primary disease. No adverse events related to radiation therapy were observed. In this case, radiation therapy was found to be effective at an early stage in relieving pain from malignant psoas syndrome, which was difficult to control with multiple pharmacological treatments. Given its effectiveness in early pain relief without adverse events, radiation therapy should be actively considered as a treatment option for malignant psoas syndrome.
恶性腰大肌综合征是由恶性肿瘤浸润腰大肌引起的,其特征为严重疼痛。目前,针对这种疾病尚未确立明确的诊断或治疗方法。尽管常使用多种药物来缓解疼痛,但疼痛管理往往具有挑战性,且存在多种治疗选择。在此,我们报告一例60多岁的日本男性病例,该患者因黏液样脂肪肉瘤转移而被诊断为恶性腰大肌综合征。尽管针对严重疼痛接受了多种药物治疗,但其效果并不理想。因此,计划并开始进行姑息性放射治疗以缓解疼痛。我们讨论了放射治疗方法。由于此前没有关于单次剂量超过3 Gy治疗的文献,且主治医生预计患者存活时间稍长,我们决定进行13次分割、总剂量为39 Gy的放射治疗。在8次分割给予24 Gy后早期疼痛得到缓解。疼痛改善后放射治疗持续进行且方案不变。由于全身转移进展导致患者一般状况恶化,在12次分割给予36 Gy后治疗终止。患者在治疗结束后两天(放射治疗开始后18天)因原发疾病加重死亡。未观察到与放射治疗相关的不良事件。在该病例中,发现放射治疗在早期对缓解恶性腰大肌综合征引起的疼痛有效,而这种疼痛用多种药物治疗难以控制。鉴于其在早期缓解疼痛且无不良事件的有效性,放射治疗应被积极考虑作为恶性腰大肌综合征的一种治疗选择。